Tianjin Medical Journal ›› 2020, Vol. 48 ›› Issue (6): 479-482.

Previous Articles     Next Articles

Discussion on the treatment of COVID-19 in Tianjin

YU Hong-zhi1, XU Lei2, CONG Hong-liang3, WU Qi1△   

  1. 1 Department of Respiratory and Critical Care Medicine, Tianjin Haihe Hospital, Tianjin Institute of Respiratory Disease, Tianjin 300350, China; 2 Department of Critical Care Medicine, Tianjin Third Central Hospital; 3 Department of Cardiology, Tianjin Chest Hospital
  • Received:2020-03-31 Revised:2020-04-09 Published:2020-06-15 Online:2020-06-15
  • Contact: wu qi E-mail:WQ572004@163.com

Abstract: Abstract: Novel coronavirus disease (COVID-19) pneumonia is a new infectious disease. Although great progress has been made in the clinical diagnosis, treatment and prevention in China, clinical treatment still faces many challenges. COVID-19 has special clinical symptoms and imaging manifestations, and the virus has special biological characteristics, which requires medical experts to continuously accumulate knowledge and experience, so as to further standardize the clinical diagnosis and therapeutic plan. In order to better guide the clinical practice, this paper summarized the general treatment information of 136 confirmed cases in Tianjin and discussed the experience of the early diagnosis, early warning of severe cases, anti-infection strategy and management of critical patient.

Key words: pneumonia,viral, coronavirus, COVID-19, SARS-CoV-2, experience in treatment, clinical characteristics, Tianjin